Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Yn: Cochrane Library, Cyfrol 2015, Rhif 12, CD011964, 07.12.2015.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer
AU - Rai, N.
AU - Campaneria, R.
AU - Snell, K.
AU - Mallett, S.
AU - Bayliss, S.E.
AU - Neal, R.D.
AU - Balogun, M.
AU - Kehoe, S.
AU - Deeks, J.K.
AU - Sundar, S.
AU - Davenport, C.
PY - 2015/12/7
Y1 - 2015/12/7
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To establish the accuracy of symptoms, ultrasound and biomarkers alone or in combination for the diagnosis of ovarian cancer in pre- and postmenopausal women. To compare the accuracy of different tests or test combinations. We will investigate the following sources of heterogeneity: Population Clinical setting (generalist/primary care/community/family practice) versus specialist setting (cancer unit/cancer centre/gynaecological oncology) Menopausal status Index tests Test positivity threshold Experience of the ultrasound test operator (general sonographers versus specialist interest) Target condition Histological subtype Study quality Case-control versus other study designs Study quality: for study participants not receiving surgery initially following a negative index test result: 12 months follow-up versus less than 12 months follow-up
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To establish the accuracy of symptoms, ultrasound and biomarkers alone or in combination for the diagnosis of ovarian cancer in pre- and postmenopausal women. To compare the accuracy of different tests or test combinations. We will investigate the following sources of heterogeneity: Population Clinical setting (generalist/primary care/community/family practice) versus specialist setting (cancer unit/cancer centre/gynaecological oncology) Menopausal status Index tests Test positivity threshold Experience of the ultrasound test operator (general sonographers versus specialist interest) Target condition Histological subtype Study quality Case-control versus other study designs Study quality: for study participants not receiving surgery initially following a negative index test result: 12 months follow-up versus less than 12 months follow-up
U2 - 10.1002/14651858.CD011964
DO - 10.1002/14651858.CD011964
M3 - Article
VL - 2015
JO - Cochrane Library
JF - Cochrane Library
SN - 1465-1858
IS - 12
M1 - CD011964
ER -